MedTrace Logo

Pain and Sensory Changes Assessment in HIV+ Patients

NCT00422695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143

Last updated 2017-04-13

Study results available
· View outcomes & findings →

Summary

There are about 42 million people in the world afflicted with HIV or AIDS with about 1 million patients in the US.

The epidemiology of orofacial pain has been reported extensively in the literature, yet the prevalence severity and level of pain affecting the head, face, neck and intraoral structures has not been explored in a population of HIV infected individuals.

Pain, in general terms, is a common experience in HIV infected patients, even in the absence of cancer or opportunistic infections. There is a variation in the prevalence of pain in these individuals depending on the stage of disease, care setting, and study methods. The purpose of this study is:

1. To investigate the prevalence of orofacial pain in HIV infected patients during routine dental clinical assessment.
2. To study the sensory phenotype of HIV+ patients and healthy volunteers using Quantitative Sensory Testing:

* To detect the presence of sensory aberrations in the orofacial complex;
* To identify which nerve types are involved;
* To identify the type of orofacial pain based on both sensory testing and clinical findings.
3. To determine psychological condition and nutrition status in patients with HIV.
4. To find associations between inherited traits and development of neuropathic pain.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • University of Medicine and Dentistry of New Jersey

    lead OTHER

Principal Investigators

  • Eli Eliav, DMD PhD · Rutgers, The State University of New Jersey

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00422695 on ClinicalTrials.gov